Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Caris Life Sciences,?Inc. (CAI : NSDQ)
 
 • Company Description   
Caris Life Sciences Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring and precision medicine enabling aspects. Caris Life Sciences Inc. is based in Irving, TX.

Number of Employees: 1,846

 
 • Price / Volume Information   
Yesterday's Closing Price: $15.55 Daily Weekly Monthly
20 Day Moving Average: 3,130,189 shares
Shares Outstanding: 282.68 (millions)
Market Capitalization: $4,395.69 (millions)
Beta:
52 Week High: $42.50
52 Week Low: $14.19
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -21.42% -25.26%
12 Week -19.18% -25.28%
Year To Date -42.36% -45.68%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
750 W JOHN CARPENTER FREEWAY SUITE 800
-
IRVING,TX 75039
USA		 ph: 866-771-8946
fax: -		 ir@carisls.com http://www.carislifesciences.com
 
 • General Corporate Information   
Officers
David Dean Halbert - Chief Executive Officer and Chairman
Brian J. Brille - Vice Chairman and Executive Vice President
Luke Power - Senior Vice President; Chief Financial Officer; an
Peter M. Castleman - Director
David Fredrickson - Director

Peer Information
Caris Life Sciences,?Inc. (CHCR)
Caris Life Sciences,?Inc. (ESRX)
Caris Life Sciences,?Inc. (MYDP)
Caris Life Sciences,?Inc. (COR)
Caris Life Sciences,?Inc. (GBCS)
Caris Life Sciences,?Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 142152107
SIC: 8071
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/11/26
Share - Related Items
Shares Outstanding: 282.68
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $4,395.69 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.01 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.10 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 159.49
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 7.41
Price/Cash Flow: 9.75
Price / Sales: 4.84
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -100.00%
Sales Growth
vs. Year Ago Period: 78.78%
vs. Previous Quarter: -26.19%
ROE
03/31/26 - 98.28
12/31/25 - 109.88
09/30/25 - -
ROA
03/31/26 - 48.87
12/31/25 - 54.08
09/30/25 - -
Current Ratio
03/31/26 - 7.05
12/31/25 - 7.85
09/30/25 - 9.93
Quick Ratio
03/31/26 - 6.52
12/31/25 - 7.35
09/30/25 - 9.36
Operating Margin
03/31/26 - 56.93
12/31/25 - 51.03
09/30/25 - -
Net Margin
03/31/26 - 3.75
12/31/25 - -8.39
09/30/25 - -
Pre-Tax Margin
03/31/26 - 3.73
12/31/25 - -8.38
09/30/25 - -
Book Value
03/31/26 - 2.10
12/31/25 - 2.05
09/30/25 - 1.70
Inventory Turnover
03/31/26 - 4.94
12/31/25 - 7.11
09/30/25 - -
Debt-to-Equity
03/31/26 - 0.64
12/31/25 - 0.66
09/30/25 - 0.79
Debt-to-Capital
03/31/26 - 39.12
12/31/25 - 39.62
09/30/25 - 44.03
 

Powered by Zacks Investment Research ©